FY2025 EPS Estimates for Henry Schein, Inc. Lowered by Analyst (NASDAQ:HSIC)

Henry Schein, Inc. (NASDAQ:HSIC) – Equities researchers at Leerink Partnrs decreased their FY2025 earnings per share (EPS) estimates for shares of Henry Schein in a note issued to investors on Tuesday, May 7th. Leerink Partnrs analyst M. Cherny now anticipates that the company will earn $5.56 per share for the year, down from their previous estimate of $5.63. Leerink Partnrs currently has a “Market Perform” rating on the stock. The consensus estimate for Henry Schein’s current full-year earnings is $5.07 per share. Leerink Partnrs also issued estimates for Henry Schein’s FY2026 earnings at $6.06 EPS and FY2027 earnings at $6.61 EPS.

A number of other research firms have also recently issued reports on HSIC. SVB Leerink initiated coverage on shares of Henry Schein in a research note on Monday, February 26th. They issued a “market perform” rating and a $78.00 target price for the company. UBS Group reduced their price objective on Henry Schein from $82.00 to $80.00 and set a “neutral” rating on the stock in a research note on Wednesday. Barrington Research raised their target price on Henry Schein from $90.00 to $92.00 and gave the company an “outperform” rating in a research note on Wednesday. JPMorgan Chase & Co. upped their price target on shares of Henry Schein from $82.00 to $88.00 and gave the stock an “overweight” rating in a research report on Wednesday, March 6th. Finally, Piper Sandler raised their price objective on shares of Henry Schein from $78.00 to $86.00 and gave the company an “overweight” rating in a research report on Monday, February 26th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $81.73.

Henry Schein Price Performance

NASDAQ:HSIC opened at $73.44 on Thursday. The company has a quick ratio of 1.00, a current ratio of 1.67 and a debt-to-equity ratio of 0.45. The firm has a market cap of $9.44 billion, a PE ratio of 23.31, a price-to-earnings-growth ratio of 1.68 and a beta of 0.87. Henry Schein has a 12 month low of $60.01 and a 12 month high of $82.63. The company’s 50-day moving average price is $72.95 and its two-hundred day moving average price is $72.35.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, May 7th. The company reported $1.10 EPS for the quarter, beating the consensus estimate of $1.01 by $0.09. The company had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.21 billion. Henry Schein had a net margin of 3.37% and a return on equity of 14.03%. The firm’s revenue for the quarter was up 3.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.21 EPS.

Institutional Trading of Henry Schein

Several hedge funds have recently added to or reduced their stakes in HSIC. McGlone Suttner Wealth Management Inc. bought a new stake in shares of Henry Schein in the fourth quarter worth about $39,000. Neo Ivy Capital Management acquired a new position in shares of Henry Schein in the 3rd quarter valued at approximately $46,000. Mather Group LLC. bought a new stake in Henry Schein during the 1st quarter worth approximately $97,000. Covestor Ltd raised its holdings in Henry Schein by 22.8% during the 3rd quarter. Covestor Ltd now owns 1,367 shares of the company’s stock worth $102,000 after buying an additional 254 shares during the period. Finally, Palisade Asset Management LLC bought a new position in Henry Schein in the first quarter valued at approximately $113,000. Institutional investors and hedge funds own 96.62% of the company’s stock.

Insiders Place Their Bets

In other news, CEO Bradford C. Connett sold 6,430 shares of the firm’s stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total value of $477,620.40. Following the transaction, the chief executive officer now directly owns 73,108 shares in the company, valued at approximately $5,430,462.24. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, CEO Bradford C. Connett sold 6,430 shares of the stock in a transaction that occurred on Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total value of $477,620.40. Following the sale, the chief executive officer now directly owns 73,108 shares in the company, valued at approximately $5,430,462.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Vice Chairman James P. Breslawski sold 2,907 shares of the business’s stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $74.37, for a total transaction of $216,193.59. Following the transaction, the insider now owns 209,562 shares of the company’s stock, valued at approximately $15,585,125.94. The disclosure for this sale can be found here. Company insiders own 1.14% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.